baber/WOPTO huggingface dataset:
Patent DE-69406681-D1 (DE)
Inventor: TREMBLAY FRANCOIS
IPC: C22B21/00
Filed: 1994-11-25
Granted: 1997-12-11
Abstract: A method of recovering an aluminum-containing metal from a scrap material containing the metal and an organic contaminant, such as paper, plastics, lacquer, paint or oil. The method involves creating a fluidized bed of solid particles, maintaining a zone of the bed at a temperature in the range of the melting point of the metal to 1000 DEG  C., introducing the scrap material into the fluidized zone to cause decoating of the metal within a time in the range of 1 to 40 seconds, at least partially melting the metal, and removing the metal material from the fluidized bed. In this way, decoating and at least partial melting is achieved essentially at the same time for improved efficiency. Metals of different melting point may also be separated from each other by providing a series of temperature zones in the fluidized bed (or in a series of fluidized beds) of progressively increasing temperature. If a limited amount of oxygen is introduced into the bed, a combustible gas is produced that can be burned to extract its energy or can be stored for later use.
Patent DE-69409960-D1 (DE)
Inventor: CROSS PETER
IPC: B01J8/02
Filed: 1994-09-13
Granted: 1998-06-04
Abstract: An improved process for continuous recovery of elemental sulphur from sulphur-bearing gas streams, especially for use in a Claus plant, employs a cyclically varying temperature profile through a catalytic bed, such that at least part of the bed is maintained as a "cold" zone at a temperature in the range 125 to 180  DEG C to promote conversion to elemental sulphur, and each part of the bed periodically becomes a "hot" zone at a temperature in the range 190 to 375  DEG C to effect removal of elemental sulphur deposits from the bed.
Patent DE-69411408-D1 (DE)
Inventor: RUSSELL DAVID B
IPC: F23C10/10
Filed: 1994-02-11
Granted: 1998-08-13
Abstract: The invention relates to a circulating fluidized bed combustor (10) comprising a fluidized bed combustion chamber, a recirculating system (20,22,24) for recirculating fluidized solids through the combustion chamber, and a plurality of fluid injection nozzles (32,34,36) disposed around the walls of the combustion chamber above the loop seal returns (26) for injecting a high velocity fluid for improved mixing gases and solids in the combustion chamber. <IMAGE>
Patent DE-69412044-D1 (DE)
Inventor: EASTLAND PHILIP HENRY DONALD
IPC: C07C29/141
Filed: 1994-01-06
Granted: 1998-09-03
Abstract: Prodn. of alcohols and diols by hydrogenation of corresp. monoesters of (di)carboxylic acids, diesters of dicarboxylic acids, lactones and mixts. compsns. (a) providing hydrogenation zone contg. charge of granular heterogeneous Cu-contg. ester hydrogenation catalyst; (b) supplying a vaporous feedstream contg. H2 and an hydrogenatable material selected from 1-4C alkyl monoesters of 8-18C monocarboxylic acids, di-1-4C alkyl diesters of 4-12C dicarboxylic acids, gamma butyrolactone and mixts. of inlet temp. above dew point of mixt.; (c) maintaining hydrogenation zone at 150-350[deg]C and pressure of 150-2,000 psia; and (d) recovering a two-phase prod. stream contg. alcohol or acid at exit temp. below dew point.
Patent DE-69412329-D1 (DE)
Inventor: DURAND LUCIEN
IPC: F16B1/02
Filed: 1994-04-15
Granted: 1998-09-17
Abstract: - Temporary link between a tool and a tool holder. - The device is characterised in that:   . the shank includes two converging edges and an opening (14) situated between the said edges, . the support member includes a mortice (15) and, between its edges, has a through-housing (21), . the removable fastening system (20) includes a unit (32) placed in register with the housing and carrying a movable lock bolt (22) located in the said housing, provided with a locking head (23) and associated with means (24) for manually forcing it into a non-obstructing and actuating position in the locking position.   - Application to machines for splitting slaughterhouse animal carcasses. <IMAGE>
Patent DE-69414723-D1 (DE)
Inventor: HERSHENSON SUSAN
IPC: A61K31/715
Filed: 1994-12-21
Granted: 1998-12-24
Abstract: The invention relates to a novel formulation of stem cell factor. The formulation contains histidine, glutamic acid, sucrose and mannitol. The formulation has a pH between 5.0 and 6.0 and has been lyophilized.
Patent DE-69426307-D1 (DE)
Inventor: SIDNEY JAMES
IPC: E04C2/42
Filed: 1994-08-22
Granted: 2000-12-21
Abstract: PCT No. PCT/AU94/00496 Sec. 371 Date Feb. 20, 1996 Sec. 102(e) Date Feb. 20, 1996 PCT Filed Aug. 22, 1994 PCT Pub. No. WO95/06174 PCT Pub. Date Mar. 2, 1995A metal lattice is provided which is formed of over-lying slats of hollow tubular form. The slats are provided with apertures in opposite side faces so that when fastened together by a rivet, the rivets are hidden from one side. In an alternative connection arrangement, the slats may be provided with tongues for location in slots in the slats. A method and apparatus for manufacturing the metal lattice is also disclosed.
Patent DE-69427233-D1 (DE)
Inventor: LUKINS EDWARD
IPC: B60C23/04
Filed: 1994-08-23
Granted: 2001-06-21
Abstract: A tire inflation valve stem comprises a stationary, radially outer stem part (3); a movable, radially inner stem part (4) slidable axially within the outer part; a compression reaction spring (20) extending between the core parts; and a flexible barrier (23) extending from one core part to the other to prevent air leakage between the parts. The flexible barrier comprises a thin walled, soft elastomeric tube sealed at its ends to the respective core parts and with an intermediate part curved back on itself in a free rolling manner within a variable length annular space between an external cylindrical surface (19) of the movable core part and an internal cylindrical surface (12) of the stationary part.
Patent DE-69427537-D1 (DE)
Inventor: BYMASTER PORTER
IPC: C07D451/04
Filed: 1994-08-18
Granted: 2001-07-26
Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.
Patent DE-69429580-D1 (DE)
Inventor: VITELLI RENATO
IPC: B02C17/14
Filed: 1994-09-26
Granted: 2002-02-07
Abstract: PCT No. PCT/IT94/00154 Sec. 371 Date Mar. 27, 1996 Sec. 102(e) Date Mar. 27, 1996 PCT Filed Sep. 26, 1994 PCT Pub. No. WO95/09043 PCT Pub. Date Apr. 6, 1995Basket for machines for mixing and grinding a number of substances in order to produce uniform mixes, such as those used for paints, with the basket in question featuring along its perimeter a circular ring (1) bound at the inner and outer edges by micro-perforated walls (2 and 3), and with this ring functioning as a channel inside of which microspheres made of glass or of other suitable materials are placed; the central portion of the basket, when viewed from below, appears empty in the middle, with this space being bound along its perimeter by the circular channel (1).
Patent DE-69430533-D1 (DE)
Inventor: AUDA MAHROUSSA
IPC: C09K23/00
Filed: 1994-07-27
Granted: 2002-06-06
Abstract: Oil based emulsifiable concentrates include (a) at least one oil component; (b) at least one surfactant hydrocarboxyl saccharide, particularly a surfactant hydrocarbyl polysaccharide (HPS); and (c) at least one other non-ionic surfactant. The concentrates are typically homogeneous for at least 24 hours and emulsify readily on dilution into water. The concentrates preferably also include: (d) an antifoaming agent, especially a polysiloxane; and/or (e) at least one chemical agent specific to the intended use of the composition, such as an agrochemical, especially a herbicide, or a metal corrosion inhibitor. The concentrates can be diluted readily in water to give emulsion formulations which can be sprayed onto substrates, e.g. when the chemical agent is a herbicide, onto weeds.
Patent DE-69430625-D1 (DE)
Inventor: NAKAYAMA CHIAKI
IPC: G01N33/493
Filed: 1994-12-27
Granted: 2002-06-20
Abstract: The invention relates to a method of sampling urine in a toilet provided with a standard type water closet, and an apparatus (26) therefor. An elongated urine taking vessel (96) extending transversely of the closet is used. The urine taking vessel (96) is taken to an optimum urine taking position within a bowl space (16A) along an inner surface of bowl (16) of the closet while being supported such that an axis of the urine taking vessel is extended perpendicular to a vertical, central surface of the closet and horizontally. As the urine taking vessel can accommodate a deviation of an individual urination in a longitudinal direction and in a right and left direction, it is possible to efficiently take urine with the urine taking vessel of a small size. The urine taking vessel (96) is mounted to an end of a swing arm (94) having a horizontal axis of rotation. In a simplest embodiment, the swing arm (94) is given only a rotating movement. In a more sophisticated embodiment, the urine taking vessel is taken to a urine taking position by the swing arm (94) performing rotating and translating movements. After use, the urine taking vessel is received in a washing chamber (162), which is substantially concealed by a front portion of a seat (24), and undergoes washing by pressure water jetted from a jet nozzle (184). In a preferred embodiment, a urine sampling apparatus (26) is mounted to the seat. <IMAGE>
Patent DE-69431536-D1 (DE)
Inventor: LUDWIG LESTER F
IPC: G06F13/00
Filed: 1994-03-16
Granted: 2002-11-14
Abstract: A teleconferencing system that integrates separate real-time and asynchronous networks - the former for real-time audio and video, and the latter for control signals and textual, graphical and other data - in a manner which closely approximates the experience of face-to-face collaboration. The system provides an audio/video (AV) path (13) for carrying AV signal among the workstations, a video mosaic generator (36) for combining images, and an audio summer or mixer (38). At least part of the AV path (13b) is implemented with unshielded twisted pair wiring. The system architecture is readily scalable to the largest enterprise network environments. It accommodates differing levels of collaborative capabilities available to individual users and permits high-quality audio and video capabilities to be readily superimposed onto existing personal computers and workstations (12) and their interconnecting LANs (10) and WANs (15). In the case of a plurality of geographically dispersed LANs (10) interconnected by a WAN (15), the demands made on the WAN are significantly reduced by employing multi-hopping techniques, including avoiding the unnecessary decompression of data at intermediate hops, as well as video mosaicing and cut-and-paste technology.
Patent DE-69434752-D1 (DE)
Inventor: SACKLER RICHARD
IPC: A61K31/137
Filed: 1994-11-22
Granted: 2006-07-06
Abstract: Oral sustained release opioid formulation comprises: an opioid analgesic, a retardant material to cause the opioid analgesic to be released at a rate to provide an analgesic effect after oral admin. to a human patient for 24 hrs, the formulation when administered in humans providing an initially rapid rate of rise in the plasma conc. of the opioid characterised by providing an absorption half-life of 1-8 hrs. in the fastened state. Method for titrating human patients with a sustained release oral opioid formulation comprises: 1) administering to a human patient on a once-a-day basis a unit dose of an oral sustained release formulation comprising a dose of an opioid analgesic and a retardant material as described above, 2) monitoring pharmacokinetic and pharmacodynamic parameters elicited by the formulation in the human patient and determining whether the pharmacokinetic and/or pharmacodynamic  parameters are appropriate to treat the patient on a repeated basis, 3) titrating t he patient by adjusting the dose of the opioid analgesic administered to the patient by administering a unit dose of the sustained release opioid analgesic formulation if it is determined that the pharmacokinetic and/or the pharmacodynamic parameters are not satisfactory or maintaining the dose of the opioid analgesic in the unit dose at a previously administered amt. if the pharmacokinetic and/or pharmacodynamic parameters are deemed appropriate, 4) continuing the step 3 titration by adjusting the dose of the opioid analgesic until appropriate steady state pharmacokinetic and/or pharmacodynamic parameters are achieved in the patient, and 5) continuing the admin. of the dose of the opioid analgesic in the oral sustained release formulation on a once-a-day basis until treatment is terminated.
Patent DE-69500555-D1 (DE)
Inventor: DE MERINGO ALAIN
IPC: C03C13/00
Filed: 1995-05-24
Granted: 1997-09-18
Abstract: A biologically degradable glass-fiber composition characterized by the following constituents in percent by weight:SiO<sub>2</sub>45 to 60Al<sub>2</sub>O<sub>3</sub>less than 2CaO + MgO10 to 16Na<sub>2</sub>O + K<sub>2</sub>Omore than 18 to 23B<sub>2</sub>O<sub>3</sub>10 to 18P<sub>2</sub>O<sub>5</sub>0 to 4BaO0 to 1Diverse0 to 2.
Patent DE-69502497-D1 (DE)
Inventor: PYNSON JOEL
IPC: A61F9/007
Filed: 1995-06-20
Granted: 1998-06-18
Abstract: PCT No. PCT/FR95/00818 Sec. 371 Date Dec. 11, 1996 Sec. 102(e) Date Dec. 11, 1996 PCT Filed Jun. 20, 1995 PCT Pub. No. WO95/35078 PCT Pub. Date Dec. 28, 1995A sclerotomy implant intended to be set in place in the sclera of the eye in order to provide for a continuous flow of aqueous humor through the trabecula for the treatment of a glaucoma. This implant is configured like a platelet made of biocompatible material and comprising an intrascleral portion (1) and a sub-conjuctival portion (5), the latter being adapted to come out of the sclera and penetrate under the conjunctiva. Retaining flanges (7a, 7b) provide for the blocking of the implant in the trap under the scleral flap. The implant comprises at least one continuous flow passage from its trabecular extremity (2) applied against the trabecula up to its external extremity (6) inserted in the conjunctiva.
Patent DE-69512230-D1 (DE)
Inventor: ALFERINK PETRUS
IPC: C08F4/32
Filed: 1995-05-03
Granted: 1999-10-21
Abstract: PCT No. PCT/EP95/01679 Sec. 371 Date Oct. 25, 1996 Sec. 102(e) Date Oct. 25, 1996 PCT Filed May 3, 1995 PCT Pub. No. WO95/30697 PCT Pub. Date Nov. 16, 1995A method of radically (co)polymerizing vinyl ester, vinyl halide, diene, acrylonitrile and  alpha -olefin monomers, optionally with one or more ethylenically unsaturated monomers, with a polymerization initiator in the presence of an amount of at least one peroxyacid chain transfer agent effective to reduce the molecular weight of the (co)polymer in comparison to a (co)polymer made by the same process without chain transfer agent, is disclosed. Also disclosed are (co)polymers produced by the method and the use of particular peroxyacids as chain transfer agents in the radical polymerization of one or more ethylenically unsaturated monomers. These peroxyacids give a significant molecular weight reduction, and are useful with a variety of different polymerization initiators.
Patent DE-69527089-D1 (DE)
Inventor: KATINGER HERMANN
IPC: G01N33/569
Filed: 1995-04-19
Granted: 2002-07-18
Abstract: Disclosed are antibodies which can be used for the manufacture of vaccines for active and/or passive immunization of persons in need of such treatment. The invention also provides for human monoclonal antibodies that are functionally equivalent to the above-mentioned antibodies produced by any one of the cell lines CL1 through CL6 (deposited at the European Collection of Animal Cell Cultures (ECACC) at the PHLS in Porton Down, Salisbury, UK). Also provided are hybridoma and/or CHO cell lines producing any one of the antibodies disclosed and claimed herein. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention and/or therapeutical treatment of HIV-1 infections in vitro and in vivo.
Patent DE-69527959-D1 (DE)
Inventor: SHENKIN LEE
IPC: G01N33/49
Filed: 1995-05-23
Granted: 2002-10-02
Abstract: A process for determining the reticulocyte population in blood samples, which process includes the use of coriphosphine O to stain reticulocytes and which process is particularly suitable for detection by flow cytometry techniques.
Patent DE-69530218-D1 (DE)
Inventor: HAEMAELAEINEN JARI
IPC: H04W28/18
Filed: 1995-09-26
Granted: 2003-05-08
Abstract: A data transmission in a digital mobile communication system employing a so-called multi-channel access technique, in which one or more traffic channels may be allocated to a mobile station for data transmission in accordance with the data transfer rate required by the application using the mobile station. Upon establishing a data call, the mobile station indicates to the mobile communication network the maximum and optionally the minimum requirements for the user data transfer rate. The mobile communication network assigns the mobile station for a data call a channel configuration consisting of one or more traffic channels in connection with call set-up or handover, the channel configuration depending on the resources currently available in the mobile communication network and enabling performance of the data channel, which is not lower than the minimum requirement and not higher than the maximum requirement.
Patent DE-69613583-D1 (DE)
Inventor: JOHANSSON MATS
IPC: F16L55/165
Filed: 1996-09-20
Granted: 2001-08-02
Abstract: A method of socketing a pipe of oriented plastic having an annular groove inside the socket. An end portion (15) of the pipe is pushed onto a cylindrical mandrel element (11) and the region (l1) of the end portion at the opening thereof where the groove is to be located is heated to a temperature above the glass transition temperature of amorphous plastic and the crystalline melting point of crystalline plastic, respectively. The rest of the end portion is maintained at a temperature below the glass transition temperature or the crystalline melting point, respectively. The end portion (15) when said region is at a temperature above the glass transition temperature or the crystalline melting point, respectively, is pushed onto a second mandrel element (13) axially aligned with said first mandrel element the bottom portion of the socket being formed by said second mandrel element (13). The rest of the end portion is expanded to form the bottom portion of the socket. The end portion of the pipe is cooled and is then withdrawn from the mandrel elements.
Patent DE-69632288-D1 (DE)
Inventor: PERINI UMBERTO
IPC: G01N15/02
Filed: 1996-05-31
Granted: 2004-06-03
Abstract: The granulometer uses a measuring laser beam (9) to illuminate particulate and, through the measure of the distribution of the light diffused by the examined particulate and gathered by a collecting lens (11), measures the concentration of particulate in the fluid in low concentration standards, the laser beam (9) being a converging one focused on a laser opaque shell (12) that partly covers the same lens. <IMAGE>
Patent DE-69633510-D1 (DE)
Inventor: DUDLEY JOHN
IPC: F16L37/091
Filed: 1996-07-05
Granted: 2004-11-04
Abstract: A tube coupling system comprises a coupling having a main body (2) which defines a tube receiving bore, the tube receiving bore being provided with a seal (4) to seal around the outer surface of a tube (T) received within the bore and being provided with tube gripping means such as a split ring (8) for engaging the outer surface of the tube. The system further comprises a release tool (21) which may be moved axially with respect to the bore to release the tube gripping means (8) from the tube (T). The release tool is removable and the tube gripping means has an outwardly facing tapering surface (28) which is engaged by a corresponding surface on the release tool. The tool is a two part or hinged sleeve to enable it to be placed over, and removed from, the tube (T).
Patent DE-69705637-D1 (DE)
Inventor: WORTHINGTON KEITH
IPC: C08G18/50
Filed: 1997-11-24
Granted: 2001-08-16
Abstract: There is disclosed an adhesive for bonding elastomers with improved dynamic fatigue resistance comprising an halogenated polymer which can be cured and stabilised and which contains isocyanate with a functionality of between 2.1 and 2.6. The adhesive may be a bonding agent or coating for incorporation into a bonding process. It is particularly useful for bonding polyurethane tread or sidewall components to a tyre.
Patent DE-69717479-D1 (DE)
Inventor: JACKSON JAMES ROGER
IPC: C03C13/06
Filed: 1997-09-26
Granted: 2003-01-09
Abstract: A process for making mineral wool fibers having high-temperature stability consisting essentially of: (a) preparing a mixture containing basalt and a quantity of uncalcined raw bauxite sufficient to provide the resulting fibers with an alumina content of at least 18 weight percent, preferably of from 19 to 23 weight percent; (b) heating the mixture to a temperature sufficient to form a substantially homogeneous melt, e.g., in a cupola furnace using coke in a quantity of from about 11 to 25 percent by weight of the mixture; and (c) forming the melt into fibers. The mixture may optionally contain a flux, e.g., limestone and/or dolomite, such as a flux providing a weight ratio of limestone plus dolomite to basalt of less than about 0.6, e.g., 0.1-0.4. The mixture may also contain slag in a weight ratio of slag:basalt of less than about 1.0, more preferably about 0.6. At least about 90% of the uncalcined raw bauxite is of a particle size capable of passing through a 150-mm mesh screen but incapable of passing through a 25-mm mesh screen, more preferably capable of passing through a 125-mm mesh screen but not a 50-mm mesh screen. Preferably, the bauxite has a bound-water content of 10-33 weight percent. The weight ratio of alumina to silica in the fibers is preferably greater than 0.35.
Patent DE-69805665-D1 (DE)
Inventor: MARUYAMA TORU
IPC: A61P1/16
Filed: 1998-01-26
Granted: 2002-07-11
Abstract: A 3,7-dithiaprostanoic acid derivative of the formula (I) <CHEM> (wherein R<1> is OH, C1-4 alkoxy, NR<6>R<7> (wherein R<6>, R<7> are H, C1-4);R<2> is H, OH; R<3> is (i)alkyl, alkenyl, alkynyl (ii) phenyl, cycloalkyl (iii) alkyl, alkenyl, alkynyl substituted by phenyl, cycloalkyl (when R<2> is H, alkyl, alkenyl, alkynyl in (i) or (iii) may be substituted by OH) possesses a binding activity for PGE2 receptor (especially for EP4). Therefore they are useful for the treatment and/or prevention of immunologic diseases (autoimmune diseases, organ transplantation etc.), asthma, abnormal bone formation, neuronal cell death, liver damage, nephritis, hypertension, myocardiac ischemia etc.
Patent DE-69807692-D1 (DE)
Inventor: HABERMEHL LYLE
IPC: F16B25/00
Filed: 1998-06-19
Granted: 2002-10-10
Abstract: A screwdriver for driving collated screws including a slide body coupled to a housing for reciprocal displacement in a cycle including a retraction stroke and an extension stroke. A lever pivotably mounted to the slide body carries at one end a cam pin received in a cam slot in the housing with the other end of the lever advancing successive screws in the screwstrip, the cam slot having first and second camming surfaces for selective engagement by the cam pin to vary the relative positionning of the lever to be different for the same position if the slide body in the housing in the retraction strokes than in the extension stroke.
Patent DE-69810323-D1 (DE)
Inventor: DECROUPET DANIEL
IPC: C03C17/38
Filed: 1998-08-10
Granted: 2003-01-30
Abstract: A method of producing a copper-based mirror for use in furnishings and decoration comprises a transparent vitreous substrate and a reflective copper layer, characterised in that the substrate is treated with an aqueous solution of stannous chloride prior to the so-treated substrate being covered by a reflective copper layer, and the reflective copper layer is applied by a vacuum deposition to a thickness of at least 40 nm.